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Abstract
Cardiac magnetic resonance imaging (CMR) with adenosine-stress myocardial perfusion is gaining
importance for the detection and quantification of coronary artery disease (CAD). However, there
is little knowledge about patients with CMR-detected ischemia, but having no relevant stenosis as
seen on coronary angiography (CA). The aims of our study were to characterize these patients by
CMR and CA and evaluate correlations and potential reasons for the ischemic findings. 73 patients
with an indication for CA were first scanned on a 1.5T whole-body CMR-scanner including
adenosine-stress first-pass perfusion. The images were analyzed by two independent investigators
for myocardial perfusion which was classified as subendocardial ischemia (n = 22), no perfusion
deficit (n = 27, control 1), or more than subendocardial ischemia (n = 24, control 2). All patients
underwent CA, and a highly significant correlation between the classification of CMR perfusion
deficit and the degree of coronary luminal narrowing was found. For quantification of coronary
blood flow, corrected Thrombolysis in Myocardial Infarction (TIMI) frame count (TFC) was
evaluated for the left anterior descending (LAD), circumflex (LCX) and right coronary artery
(RCA). The main result was that corrected TFC in all coronaries was significantly increased in study
patients compared to both control 1 and to control 2 patients. Study patients had hypertension or
diabetes more often than control 1 patients. In conclusion, patients with CMR detected
subendocardial ischemia have prolonged coronary blood flow. In connection with normal resting
flow values in CAD, this supports the hypothesis of underlying coronary microvascular impairment.
CMR stress perfusion differentiates non-invasively between this entity and relevant CAD.
Introduction
The assessment of myocardial ischemia is an essential
component for the further diagnostic and therapeutic
decision making in patients presenting with angina and
suspected coronary artery disease (CAD). However,
10–30% of these patients with diagnosed ischemia show
no pathological findings in coronary angiograms [1,2].
Most studies suggested coronary microangiopathy to be
the cause for angina in this patient collective [3-5].
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The use of cardiac magnetic resonance (CMR) including
pharmacologically induced stress perfusion as an emerg-
ing non-invasive method for the imaging of myocardial
ischemia is supported by rapidly growing evidence of its
accuracy in predicting relevant coronary stenosis [6-11].
However, knowledge on its proposed capability for also
detecting subendocardial perfusion deficit consistent with
small vessel disease [12] is limited. As angiographic corre-
late in these patients, studies have suggested microvascu-
lar perfusion deficit [3,5,13]. For the quantification of
coronary blood flow, Thrombolysis in Myocardial Infarc-
tion (TIMI) frame count (TFC) [14,15] proved to be a sim-
ple, reproducible and objective index [5,16-19]. The aims
of our study were
1. to correlate CMR detected subendocardial perfusion
deficit proposed for coronary small vessel disease with
angiographically determined coronary blood flow by cor-
rected TFC
2. and to compare these findings with CAD.
Methods
Study population
During a three month period, we prospectively enrolled
consecutive patients scheduled for coronary x-ray angiog-
raphy (CA) who had previously undergone adenosine
stress CMR examination and shown subendocardial per-
fusion deficit. Patients without perfusion deficit and
patients with more than subendocardial perfusion deficit
in CMR were enrolled in equal proportions to serve as
control groups. The exclusion criteria were an internal
pacemaker or defibrillator, contraindications for adenos-
ine infusion, or inability to give written informed consent.
Written informed consent was obtained from all patients.
Patients with a history of myocardial infarction or in
whom Late Gadolinium Enhancement (LGE) could be
visualized were excluded from the study. All anti anginal
medication and caffein containing beverages were
stopped at least 24 hours before CMR examination.
Study protocol
A 12-lead surface ECG was obtained for each patient. All
patients were examined clinically and cardiovascular risk
factors such as hypertension, diabetes mellitus, hypercho-
lesterolemia, smoking and family disposition for CAD
were assessed. In case of claustrophobia mild sedation
with midazolame was offered.
CMR Examination
All CMR studies were performed with a 1.5T magnetic res-
onance system (Signa Excite®, GE Medical Systems, Mil-
waukee, USA) using an 8-element phased array surface
coil (Cardiac coil, GE Medical Systems). Left ventricular
(LV) parameters were measured using long-axis (two-
chamber and four-chamber-views) functional steady-state
free precession (SSFP) sequence images as part of our clin-
ical routine protocol. After infusion of adenosine at a con-
stant rate of 140 μg/kg per minute over three minutes
(Spectris MR injector, Medrad, Indianola, USA) first-pass
kinetic of a gadolinium-based contrast agent (Omniscan®,
GE Healthcare Buchler, Germany; 0.1 mmol/kg) was
measured in 4 contiguous short axis orientations at every
heart beat using a hybrid gradient echo/echo-planar pulse
sequence (echo time 1.2 ms, flip angle 25°, slice thickness
8 mm, field of view 32–34 × 24–25.5 cm, matrix 128 ×
96) as previously described [7,20]. Echo time was reduced
to 1.2 ms for reducing susceptibility artifact as sometimes
seen in gradient echo sequences [21]. Ten minutes after
stress perfusion a second perfusion study with the same
orientation and with the same setting was performed at
rest without adenosine infusion. Ten minutes after this
second bolus, LGE images were acquired by using an
inversion-recovery prepared gated fast-gradient echo-
pulse sequence (repetition time 6.7 ms; echo time 3.3 ms;
flip 20°; inversion time individually adjusted; slice thick-
ness 8 mm; rectangular field of view 30 to 34 cm; matrix
256 × 160). Again, three long axes, 4–5 short axes as
planned in the perfusion study as well as contiguous short
axes views using a 3D 20 slice sequence were acquired.
CMR analysis
Two experienced investigators evaluated all CMR studies
in consensus. If consensus could not be achieved, a third
opinion was included. Image analysis was performed with
the standard software provided by the CMR system man-
ufacturer (Advantage Workstation, GE Medical System).
Image analysis was performed visually for reducing the
rate of false positive results due to rim artifacts as previ-
ously reported [22]. Secondly, we compared stress to rest
perfusion to reduce the potential rate of artifacts. If a def-
icit was equally present at stress and rest, if it did not fol-
low the subendocardial border, if ghosting artifacts could
be seen or if it "blinked" bright and dark it was not
regarded as an evident hypoperfusion, but a potential arti-
fact. Such cases were not included into the study. Seg-
ments were classified according to AHA
recommendations [23] and evaluated for inducible
hypoperfusion during the stress first-pass sequence and
classified as "no hypoperfusion", "subendocardial hypop-
erfusion" [12] or "relevant hypoperfusion" indicative of
relevant coronary artery stenosis [6,7] in comparison to
rest perfusion images according to following criteria:
- Patients were classified as having small vessel disease, if
diffuse subendocardial hypoperfusion [12] (affecting ≤ 1/
3 of myocardial wall thickness and myocardial areas sup-
plied at least by two different coronary arteries or circum-
ferential perfusion deficit) and lasting for maximum five
heart beats after maximal signal peak intensity in the LVJournal of Cardiovascular Magnetic Resonance 2008, 10:8 http://www.jcmr-online.com/content/10/1/8
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cavity [24]. Patients with a lesser degree of hypoperfusion
(such as ≤ 1/3 of myocardial wall thickness in only one
territory) were not included.
- Patients with regional perfusion deficit of > 1/3 wall
thickness and lasting for more than five heart beats were
classified as having CAD with ≥ 70% luminal narrowing
[7]. Patients with a lesser degree of regional hypoper-
fusion (such < 5 beats of stress perfusion defect regardless
of affected myocardial wall thickness or ≥ 5 beats but ≤ 1/
3 of myocardial wall thickness in one territory) were not
included. See figure 1 for examples of our patients groups.
Patients with small vessel disease were analyzed as study
patients, patients with no perfusion deficit as "control 1"
and patients with perfusion deficit consistent with CAD as
"control 2". Classification was performed before CA.
Coronary angiography
All patients underwent CA within 48 hours after CMR
examination. Angiographic case study data were collected
and analyzed for affected coronary arteries and degree of
luminal reduction.
Afterwards stored angiograms were assessed for corrected
TFC for each coronary vessel [14]. TFC analysis was per-
formed by the physician in charge with CA evaluation
before CMR data disclosure. The corrected TFC is the
number of cine frames required for contrast to first reach
standardized distal coronary landmarks [14,15]. In our
patients, CA was performed by hand injection of contrast
medium via 5 French catheters and filmed at 12.5 frames/
s. Since the original TFC is described for a cinefilm speed
of 30 frames/sec, an adaptation was performed as previ-
ously reported [15]. Therefore, frame counts were multi-
plied by 2.4 (correction factor). TFC for coronary arteries
with normal flow is different in the left anterior descend-
ing (LAD) compared to the left circumflex (LCX) and right
coronary artery (RCA) because of the larger vessel length.
To adapt those differences and to provide comparable
results of TIMI frame count for the different vessels, TIMI
frame count of the LAD was divided through a correction
factor of 1.7 [15].
Statistical analysis
Data are reported as mean ± standard deviation. Continu-
ous variables between groups were compared by t-test for
unpaired observations. Nominal data were compared by
Fisher's exact test. Categorial data were compared by Wil-
coxon signed rank test for matched pairs. Correlation was
assessed by means of correlation coefficient κ and regres-
sion coefficient R2. In all cases, a p value < 0.05 was con-
sidered statistically significant. 95% confidence intervals
(CI 95%) are given. Analyses were performed with com-
mercially available statistic software (StatView 5).
Results
Twenty-two patients out of a total of 265 adenosine stress
CMR examinations fulfilled the entry criteria and were
enrolled to the study. Mean age was 66.0 ± 12.5 years, 14
(64%) patients were male and 8 (36%) female. 9/22 study
patients had previous stress testing (8 bicycle ergometry, 1
dobutamine stress echocardiography), all with pathologi-
cal findings. The remainder had been referred for stress
CMR without previous stress testing. Fifty-one patients
formed the control groups. Patients' characteristics are
given in table 1.
Adenosine-stress CMR perfusion images Figure 1
Adenosine-stress CMR perfusion images. With (A) no perfusion deficit, (B) diffuse circumferential subendocardial per-
fusion deficit and (C) perfusion deficit affecting more than subendocardial layers in the LAD perfusion territory.Journal of Cardiovascular Magnetic Resonance 2008, 10:8 http://www.jcmr-online.com/content/10/1/8
Page 4 of 9
(page number not for citation purposes)
CMR
CMR examination was performed in all 73 patients with-
out relevant complications or adverse events. Image qual-
ity was sufficient for further analysis in all patients with
primary investigators consensus in 71/73 cases and inclu-
sion of a third opinion in two cases. Subendocardial per-
fusion deficit during stress perfusion in comparison to rest
perfusion was found in 22 (30%) patients, who formed
the study group. In 27 (37%) patients no perfusion deficit
could be observed (control 1), a relevant perfusion deficit
was visualized in 24 (33%) patients (control 2). Patient
groups did not differ significantly in age or gender (see
table 1).
CMR-derived LV parameters in study patients compared
to controls were as follows: LV mass (g) 135 ± 36 (control
1: 119 ± 31, p: 0.17; control 2: 129 ± 36, p: 0.65), LV ejec-
tion fraction (%) 60.3 ± 8.8 (control 1: 61.7 ± 8.1, p: 0.60;
control 2: 60.5 ± 7.2, p: 0.92), LV wall stress (N/m2x1000)
43.3 ± 8.8 (control 1: 40.0 ± 7.8, p: 0.25; control 2: 41.3 ±
8.6 g, p: 0.46).
Perfusion deficits in control 2 patients were detected in
the LAD perfusion territory in 13 [54%], in the LCX terri-
tory in 15 [63%] and in the RCA perfusion territory in 12
[50%] cases, respectively.
CA data and comparison to CMR
CA was performed in all patients without relevant compli-
cations. Coronary one-vessel disease (≥ 70% luminal nar-
rowing) was observed in 15 [21%], two-vessel disease in 9
[12%] and three-vessel disease in 6 [8%]. Mean corrected
TFC for the LAD was 21.5 ± 4.6 frames, for the LCX 33.0 ±
7.3 and for the RCA 25.9 ± 4.9.
In our study patients (only subendocardial perfusion def-
icit on CMR exam) no coronary stenosis ≥ 70% could be
shown. In contrast, all control 2 patients (relevant per-
fusion deficit in CMR) had coronary stenoses as visualized
by CA. A highly significant correlation between classifica-
tion of CMR perfusion deficit and degree of coronary
luminal narrowing was found (see table 2).
Corrected TFC in all coronary arteries was significantly
increased in study patients compared to both controls
groups: Study patients vs. control 1 (no perfusion deficit):
25.1 ± 4.9 frames vs. 20.9 ± 4.2 frames in the LAD, p =
0.002; 39.1 ± 7.7 vs. 30.1 ± 6.1 in the LCX, p < 0.0001;
29.1 ± 5.5 vs. 24.4 ± 3.8 in the RCA, p = 0.001) and vs.
control 2 (relevant myocardial ischemia): 18.7 ± 2.0 in the
LAD, p < 0.0001; 30.7 ± 4.5 in the LCX, p < 0.0001; 24.6
± 4.5 in the RCA, p = 0.004 (figure 2). Prolonged corrected
TFC (values above mean of control 1) were present in all
22 study group patients (per vessel analysis: in 60/66
(91%)), in contrast to control 2 patients (per vessel anal-
Table 1: Patients' characteristics
study patients (N = 22) control 1 (N = 27) control 2 (N = 24)
Age [years] 66.0 ± 12.5 64.6 ± 12.8 66.1 ± 9.3
Gender [masculine] 14 [64%] 16 [59%] 16 [67%]
Hypertension 15 [68%]* 10 [37%]* 16 [67%]*
Diabetes mellitus†† 9 [41%]† 4 [15%]† 11 [46%]†
Hypercholesterolemia 10 [45%] 10 [37%] 14 [58%]
Smoking 7 [32%] 11 [41%] 10 [42%]
Family history 7 [32%] 8 [30%] 8 [33%]
Angina
CCS I 9 [41%] 5 [19%]** 14 [58%]**
CCS II 8 [36%]* 18 [67%]* 7 [29%]*
CCS III 5 [23%] 4 [15%] 3 [13%]
* p < 0.05 study patients vs. control 1 and control 1 vs. control 2
†p < 0.05 study patients vs. Control 1 and p < 0.02 control 1 vs. control 2
** p < 0.01 control 1 vs. control 2
†† defined as fasting plasma glucose of > 126 mg/dl or 2-hours postload glucose of > 200 mg/dl or symptoms of diabetes mellitus and random plasma 
concentration of > 200 mg/dl (ADA criteria).
Table 2: Comparison of angiographic results with CMR group classification. Control 2 patients had significantly more often coronary 
stenosis ≥ 70% compared to study patients (p < 0.0001) and compared to control 1 patients (p < 0.0001).
0–50% coronary stenosis 51–70% coronary stenosis ≥ 70% coronary stenosis
Study patients (22) 19 (86%) 3 (14%) 0
Control 1 (27) 24 (89%) 3 (11%) 0
Control 2 (24) 0 2 (8%) 22 (92%)Journal of Cardiovascular Magnetic Resonance 2008, 10:8 http://www.jcmr-online.com/content/10/1/8
Page 5 of 9
(page number not for citation purposes)
Comparison of corrected TIMI frame count Figure 2
Comparison of corrected TIMI frame count. Between study patients and controls for LAD, LCX and RCA. Significantly 
increased frame count in study patients compared to both control groups.Journal of Cardiovascular Magnetic Resonance 2008, 10:8 http://www.jcmr-online.com/content/10/1/8
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ysis: in 12/72 (17%)). A good correlation between cor-
rected TFC in LAD and LCX was found in our study
patients (κ = 0.87; 95% CI [0.72–0.95]; p < 0.0001). Cor-
rected TFC in control 1 and control 2 patients showed a
lower correlation for LAD and LCX (κ = 0.71; 95% CI
[0.45–0.86]; p < 0.0001 and κ = 0.50; 95% CI
[0.11–0.75]; p = 0.01), respectively (figure 3). No correla-
tion between LAD and RCA or LCX and RCA TIMI frame
count was observed, respectively.
Study patients had more often hypertension (15 [68%]
versus 10 [37%], p = 0.03) and diabetes (9 [41%] versus 4
[15%], p = 0.04) than control 1 patients. Control 2
patients also had more commonly hypertension (16
[67%], p = 0.03) and diabetes (11 [46%], p = 0.02) than
control 1 patients. Patient groups did not differ for hyper-
cholesterolemia or smoking nor did study and control 2
patients differ for the above mentioned cardiovascular
risk factors.
Discussion
Patients presenting with angina pectoris, but having nor-
mal coronary arteries with normal ventricular function
and without coronary spasm have been described previ-
ously [3,4]. Coronary microangiopathy causing increased
resistance in prearteriolar coronary vessels, consequently
lowering myocardial perfusion and thus leading to
impaired coronary flow reserve has been suggested to be
the underlying pathophysiology [4,25].
Although having a good long-term prognosis [26], quality
of life is significantly impaired in patients with small ves-
sel disease, such as seen in syndrome X, mainly because of
persistent angina and decreased exercise tolerance [27]. In
addition, diagnostic clarification presently requires inva-
sive angiography.
In the attempt for non-invasive diagnosis, the results of
our study confirm that this patients' group can be diag-
nosed by adenosine-stress CMR examination as first
described by Panting et al. [12]. Their study showed
patients with syndrome X to have subendocardial diffuse
perfusion deficit patterns as seen by adenosine-stress CMR
in contrast to patients with a relevant coronary artery ste-
nosis. We used their CMR criteria for our study patient
classification with following specification: We added a
perfusion deficit lasting five heart beats or less after maxi-
mum signal intensity peak in the LV cavity as another
inclusion criterion. This is based on the study of Lauerma
et al. [24] who showed patients with perfusion deficits
lasting more than five heart beats to have relevant CAD.
Furthermore, our study extends the protocol of Panting et
al. [12] in the following aspects: First, a close time rela-
tionship between CMR and angiography (≤ 48 hours in
contrast to a mean interval of 18 months [12]); second,
use of CMR for patient classification and subsequent ang-
iographic analysis for validation; third, inclusion of two
control groups (patients without and patients having rel-
evant perfusion deficit). Most important of all, we focused
on the correlation between CMR findings and corrected
TFC in these patients.
The main finding of our study was that pure subendocar-
dial perfusion deficit as seen by CMR highly correlates
with slowed coronary artery flow as determined by cor-
rected TFC compared to both control patient groups with
or without coronary artery stenosis. This finding is con-
sistent with data from a recent study showing patients
Regression graphs with 95% confidence interval Figure 3
Regression graphs with 95% confidence interval. For correlation of LAD and LCX corrected TIMI frame count in our 
study group and in controls including regression coefficients.Journal of Cardiovascular Magnetic Resonance 2008, 10:8 http://www.jcmr-online.com/content/10/1/8
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with small vessel disease to have reduced total coronary
blush score [13]. Hence, this correlation between suben-
docardial ischemia, angina pectoris and reduced coronary
artery flow in the absence of coronary artery stenoses
strengthens the criteria used for CMR stress perfusion as
noninvasive diagnostic imaging modality in the assess-
ment of small vessel disease. Since subendocardial
ischemia is a potential source of false positive CMR inter-
pretation of CAD yielding in a lower specificity [11],
establishing criteria for detection of small vessel disease
may improve specificity and thus, the accuracy of adenos-
ine-stress CMR.
Standard LV parameters such as LV mass, ejection fraction
and wall stress were less discriminatory than stress per-
fusion. In addition, other stress tests yielding findings
compatible with myocardial ischemia in the study group
were incapable of differentiating from CAD, at least in the
subset of patients referred with previous stress tests.
Remarkably, mean resting corrected TFC was normal in
our CAD group. TFC measurement during stress was not
part of our protocol. Methodologically, it is primarily TFC
during stress ("hyperemic TFC") which has been shown to
yield decreased values in stenosed arteries, with signifi-
cant improvement after successful angioplasty with stent
placement [16]. In this context, further studies correlating
both resting and hyperemic corrected TFC with QCA
determined degree of stenosis in CAD are recommended.
Another finding of our study is that in small vessel disease
corrected TFC in the LAD correlates very well to that in
LCX. This is in concordance with findings of another
recent study in patients with microvascular dysfunction
and angina pectoris [5].
Furthermore, our results support the concept that sys-
temic hypertension and diabetes mellitus are not only risk
factors for CAD in epicardial vessels, but also for small
vessel disease. Our data strengthen the hypothesis of
microvascular functional impairment in patients with
small vessel disease: The slowed coronary artery flow
under rest causing detectable pure subendocardial
ischemia under stress conditions in the absence of coro-
nary artery stenoses suggests microvascular disease as the
cause of anginal symptoms. The causes of microvascular
dysfunction are probably multiple in these patients. Struc-
tural abnormalities like myocardial medial hypertrophy
and/or fibrosis of arteriolar vessels have been described in
a small patient cohort [28]. Regarding higher TFC in
microvascular disease compared to CAD patients with the
same risk factors, we can only hypothesize that microvas-
cular disease and CAD, although sharing diabetes and
hypertension as risk factors, form two distinct and not
necessarily concurrent disease manifestations.
The following limitations need to be mentioned for our
study. First, we did not directly measure coronary flow
velocity using a flow wire and have used instead corrected
TFC as a surrogate. This approach may be questioned in
view of the results of Chug et al [29], who found no sig-
nificant correlation between coronary flow velocity
reserve and corrected TFC in patients undergoing coro-
nary intervention. On the other hand, several studies have
shown the validity of such angiographic grading of coro-
nary blood flow by comparing it to reference methods
such as Doppler flow wire during baseline [30] and hyper-
emia [16], flow velocity measured by magnetic resonance
[19] or, most recently, by Doppler echo [31]. Flow quan-
tified by TFC is related to the risk of adverse outcomes in
acute coronary syndromes [32] or in heart transplant cor-
onary vasculopathy [33], and corrected TFC has been used
as endpoint in interventional trials on early recanalization
of the infarct-related artery [34-36]. Thus, although use of
TFC in our study seems feasible, TFC disaffirmation in the
study of Chug et al cannot be disregarded and therefore
the use of this non-invasive surrogate parameter is contra-
dictory. In view of this contradiction, studies directly com-
paring our CMR-based criteria for diagnosis of small
vessel disease with invasive coronary flow velocity meas-
urements by flow wire are required for definitive confir-
mation of our results. In this context, Muehling et al have
shown a significant correlation between invasive meas-
urement of coronary flow reserve and noninvasive evalu-
ation by CMR perfusion imaging in heart transplant
arteriopathy [37]. In CAD patients, three recent studies
have found a good correlation between CMR adenosine
stress perfusion results and the invasively measured coro-
nary fractional flow reserve [38-40]. Secondly, we did not
perform (semi-)quantitative analysis of CMR perfusion
images. Finally, while our study group patients were
included consecutively and prospectively, the two control
groups were enrolled to achieve equal proportions. Thus,
the groups do not reflect the incidence of the three condi-
tions studied. Although the very strict CMR classification
criteria should ensure homogenous groups for evaluation,
it precludes neither referral nor selection bias. Thus, while
syndrome X patients are predominantly females [12], the
unexpected high proportion of males in our study cohort
was most likely due to referral bias.
In conclusion, subendocardial perfusion deficit as seen by
CMR highly correlates to slowed coronary artery flow.
Given normal resting flow values in our patients with cor-
onary macroangiopathy, this finding is most likely due to
coronary small vessel disease. CMR allows non-invasive
detection of these patients.
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